Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Non-Current Assets: 2020-2024

Historic Non-Current Assets for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $60.3 million.

  • Oncology Institute's Non-Current Assets fell 1470.89% to $53.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $226.0 million, marking a year-over-year decrease of 1144.97%. This contributed to the annual value of $60.3 million for FY2024, which is 828.63% down from last year.
  • According to the latest figures from FY2024, Oncology Institute's Non-Current Assets is $60.3 million, which was down 828.63% from $65.7 million recorded in FY2023.
  • In the past 5 years, Oncology Institute's Non-Current Assets registered a high of $131.2 million during FY2022, and its lowest value of $36.0 million during FY2020.
  • Moreover, its 5-year median value for Non-Current Assets was $60.3 million (2024), whereas its average is $68.5 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 16577.36% in 2022, then plummeted by 4990.59% in 2023.
  • Over the past 5 years, Oncology Institute's Non-Current Assets (Annual) stood at $36.0 million in 2020, then soared by 37.29% to $49.4 million in 2021, then surged by 165.77% to $131.2 million in 2022, then crashed by 49.91% to $65.7 million in 2023, then decreased by 8.29% to $60.3 million in 2024.
  • Its last three reported values are $60.3 million in FY2024, $65.7 million for FY2023, and $131.2 million during FY2022.